As one of the most politically interesting years in recent history draws to a close, the extension of the Patient Protection and Affordable Care Act (PPACA) subsidies might take 2025’s top spot as the most significant topic in D.C., period.
It has been weeks of push/pull, give/take, will they/won’t they on the Hill. And even in the final week of official business here, uncertainty still reigns.
Let’s take a look at what is happening this week, and what it means for the future of healthcare.
Most important to know: the Senate has until Dec. 11, to vote on the subsidies. This was part of the deal that Democrats struck with Republicans to reopen the federal government back in November.
The deadline to select a 2026 health plan for the 24 million Americans who use the PPACA for health insurance coverage is Dec. 15 – and many have been holding off in anticipation of (and uncertainty with) the fate of the subsidies.
So, Congress really can’t extend the vote beyond the 11th, and it’s currently scheduled for today.
The Senate is expected to vote first on a Democratic proposal that would see the subsidies extended for three years. And while there’s near-universal support on the Democratic side for this extension, they will need a few Republican votes to pass the threshold – just as Republicans would need a few Democratic votes to pass the threshold on any bill put forward by the GOP.
While some Republicans have indicated that they are open to supporting the Democrats’ plan, many are quite staunchly opposed. Senate Majority Leader Thune has said the Democrats’ three-year extension is “not realistic,” and one Republican senator called it political “theater.”
Unfortunately for Democrats, a report came out last week showing that a government watchdog was able to successfully enroll almost 20 fake profiles in subsidized PPACA coverage. The Government Accountability Office (GAO) created these fake personas and enrolled them in PPACA plans for 2025. They received coverage throughout the year, costing the government about $10,000 per month in fraudulent subsidies, according to the report.
While the GAO stated that their tests continue, and these results can’t be generalized to the larger PPACA population, this report is particularly important because Republican lawmakers have historically been vocal about suspected fraud and mismanagement within PPACA exchanges.
Republicans have made it clear that although many don’t support a “clean” extension of the subsidies, they absolutely recognize that there needs to be some action to address health insurance affordability for their constituents. Alternative solutions that have been tossed out in the last few weeks include expanding short-term limited-duration health plans, cost-sharing reduction subsidies, and expanding access to health savings accounts.
Some have suggested overhauling the PPACA entirely.
All in all, it appears to be a flurry of potential proposals and ideas about how to address the issue, but no consensus from Congress on any one of them. Even President Trump was impacted by the lack of cohesion on the issue; he was reportedly set to unveil a healthcare policy framework last month that included a two-year extension of subsidies with some limits that have commonly been backed by Republicans.
However, once some in his party caught wind of the extension, there was allegedly “sharp backlash,” and the matter was dropped for now.
So, here we are at what many are calling a “critical juncture” for the future of healthcare costs and access to coverage. Both sides need at least some support from the other to get anything across the finish line.
But when Republicans are even split among themselves, it might be just shy of impossible for enough members to convene around a single plan. Even experts are struggling to predict what will happen this week.
So, we’ll see you back here next week to look at what went down, and what we might expect as a result in 2026.


















